Dr. Kevin Buckman, MD

NPI: 1568484855
Total Payments
$42,075
2024 Payments
$31,200
Companies
1
Transactions
17

Payment Breakdown by Category

Consulting$41,600 (98.9%)
Other$475.00 (1.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $41,600 16 98.9%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $475.00 1 1.1%

Top Paying Companies

Company Total Records Latest Year
Takeda Pharmaceuticals U.S.A., Inc. $42,075 17 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $31,200 12 Takeda Pharmaceuticals U.S.A., Inc. ($31,200)
2023 $10,875 5 Takeda Pharmaceuticals U.S.A., Inc. ($10,875)

All Payment Transactions

17 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,600.00 General
11/13/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,600.00 General
10/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,600.00 General
09/11/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,600.00 General
08/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,600.00 General
07/12/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,600.00 General
06/10/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,600.00 General
05/10/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,600.00 General
04/17/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,600.00 General
03/11/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,600.00 General
02/14/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,600.00 General
01/17/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,600.00 General
12/15/2023 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,600.00 General
11/10/2023 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,600.00 General
10/09/2023 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,600.00 General
09/13/2023 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,600.00 General
05/15/2023 Takeda Pharmaceuticals U.S.A., Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $475.00 General

About Dr. Kevin Buckman, MD

Dr. Kevin Buckman, MD is a Emergency Medicine healthcare provider based in Lodi, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568484855.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kevin Buckman, MD has received a total of $42,075 in payments from pharmaceutical and medical device companies, with $31,200 received in 2024. These payments were reported across 17 transactions from 1 company. The most common payment nature is "Consulting Fee" ($41,600).

Practice Information

  • Specialty Emergency Medicine
  • Other Specialties Occupational Medicine
  • Location Lodi, CA
  • Active Since 07/24/2006
  • Last Updated 11/02/2011
  • Taxonomy Code 207P00000X
  • Entity Type Individual
  • NPI Number 1568484855

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Emergency Medicine Doctors in Lodi